A clinical trial hosted by Memorial Sloan Kettering Cancer Center shows promising results for pancreatic cancer patients. The trial combines two primary intervention strategies to see how patients respond to treatments. Standard surgery and a customized vaccine are offering hope to those suffering from pancreatic cancer—One of the deadliest cancers in the world.
The fascinating research is completely changing how medical professionals may approach cancer research and its link with immune system health. Want to learn more? Click on.